Chris Carter
Chris Carter
Researcher PolygenicPathways
Verified email at - Homepage
Cited by
Cited by
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
DT Dexter, CJ Carter, FR Wells, F Javoy‐Agid, Y Agid, A Lees, P Jenner, ...
Journal of neurochemistry 52 (2), 381-389, 1989
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
CJ Pycock, RW Kerwin, CJ Carter
Nature 286 (5768), 74-77, 1980
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity
H Schoemaker, Y Claustre, D Fage, L Rouquier, K Chergui, O Curet, ...
Journal of Pharmacology and Experimental Therapeutics 280 (1), 83-97, 1997
Fractalkine modulates TNF‐α secretion and neurotoxicity induced by microglial activation
V Zujovic, J Benavides, X Vigé, C Carter, V Taupin
Glia 29 (4), 305-315, 2000
Microbes and Alzheimer’s disease
RF Itzhaki, R Lathe, BJ Balin, MJ Ball, EL Bearer, H Braak, MJ Bullido, ...
Journal of Alzheimer's disease: JAD 51 (4), 979, 2016
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
B Gotti, D Duverger, J Bertin, C Carter, R Dupont, J Frost, B Gaudilliere, ...
Journal of Pharmacology and Experimental Therapeutics 247 (3), 1211-1221, 1988
Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase
M Teufel, V Saudek, JP Ledig, A Bernhardt, S Boularand, A Carreau, ...
Journal of Biological Chemistry 278 (8), 6521-6531, 2003
Effect of 6‐hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat
CJ Pycock, CJ Carter, RW Kerwin
Journal of neurochemistry 34 (1), 91-99, 1980
Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat
CJ Carter, CJ Pycock
Brain Research 192, 163-176, 1980
Aspirin and salicylate protect against MPTP‐induced dopamine depletion in mice
N Aubin, O Curet, A Deffois, C Carter
Journal of neurochemistry 71 (4), 1635-1642, 2002
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
C Carter, J Benavides, P Legendre, JD Vincent, F Noel, F Thuret, ...
Journal of Pharmacology and Experimental Therapeutics 247 (3), 1222-1232, 1988
Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat
R Dennis, T: l'Heureux, C Carter, S B
J Pharmacol Exp Ther 241, 642-649, 1987
Lipid peroxidation as cause of nigral cell death in Parkinson's disease.
DT Dexter, C Carter, F Agid, Y Agid, AJ Lees, P Jenner, CD Marsden
Lancet (London, England) 2 (8507), 639-640, 1986
Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats
CJ Carter
Neuropharmacology 21 (5), 379-383, 1982
Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
CJ Carter, KG Lloyd, B Zivkovic, B Scatton
Journal of Pharmacology and Experimental Therapeutics 253 (2), 475-482, 1990
Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study
CJ Carter, R L'heureux, B Scatton
Journal of neurochemistry 51 (2), 462-468, 1988
Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage
J Benavides, D Fage, C Carter, B Scatton
Brain research 421 (1-2), 167-172, 1987
lfenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor
C Carter, JP Rivy, B Scatton
Eur. J. Pharmacol 164 (3), 611-612, 1987
Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis
CJ Carter
Neurochemistry international 50 (1), 12-38, 2007
Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability
CJ Carter
Schizophrenia research 86 (1), 1-14, 2006
The system can't perform the operation now. Try again later.
Articles 1–20